Alina started her Master thesis dealing with RIPK2 in SCLC  

Today Alina has her first day in the lab. She will investigate RIPK2 driven effects in small cell lung cancer (SCLC). Welcome Alina!

Alina studies Molecular Medicine at the Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and she also obtained her Bachelor of Science in Molecular Medicine at the FAU. Alina became interested in SCLC research during the Molecular Oncology seminar, which took place in the 2nd semester. Source: Graphics have been provided by webnode.